|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0000849043
<NAME> NEUROGEN CORPORATION
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 76,348
<SECURITIES> 38,393
<RECEIVABLES> 1,417
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 117,110
<PP&E> 38,805
<DEPRECIATION> 11,341
<TOTAL-ASSETS> 145,006
<CURRENT-LIABILITIES> 10,728
<BONDS> 0
0
0
<COMMON> 434
<OTHER-SE> (107)
<TOTAL-LIABILITY-AND-EQUITY> 145,006
<SALES> 0
<TOTAL-REVENUES> 14,605
<CGS> 0
<TOTAL-COSTS> 31,028
<OTHER-EXPENSES> (3,804)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (12,619)
<INCOME-TAX> 0
<INCOME-CONTINUING> (12,619)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (12,619)
<EPS-BASIC> (0.78)
<EPS-DILUTED> (0.78)
</TABLE>
|
|